Technology & AI

OpenAI buys biotech startup Orchestra Bio

The Indian American-led company, run by Ashoka Rajendra, will join OpenAI to advance its drug development programs at a larger scale.

By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .

This story is no longer being updated. It reflects reporting up to .

What happened

OpenAI has acquired Orchestra Bio, an Indian American-led company led by Ashoka Rajendra. The deal is aimed at expanding AI agents used in drug development. Coverage of the acquisition appeared on October 22 and 23.

Why it matters

The deal creates new opportunities and challenges for life sciences technology partners, according to coverage. It also signals the direction of OpenAI's strategy.

Coverage

More on this story

More from Technology & AI

All Technology & AI news · Technology & AI story archive